Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials.
Ludmir EB, Subbiah IM, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mandel JJ, Fang P, Smith BD, Smith GL, Pinnix CC, Sedrak MS, Kimmick GG, Stinchcombe TE, Jagsi R, Thomas CR Jr, Fuller CD, VanderWalde NA. Ludmir EB, et al. Among authors: subbiah im. J Geriatr Oncol. 2020 Apr;11(3):451-454. doi: 10.1016/j.jgo.2019.11.001. Epub 2019 Nov 8. J Geriatr Oncol. 2020. PMID: 31711757 Free PMC article.
Mentoring pearls of wisdom: Lessons learned by mentees of Arti Hurria, MD.
Magnuson A, Li D, Hsu T, Loh KP, MacKenzie A, Presley CJ, Krok-Schoen JL, Subbiah IM, Williams GR, Wong M, Soto-Perez-de-Celis E, Sedrak MS; Junior Cancer and Aging Research Group. Magnuson A, et al. Among authors: subbiah im. J Geriatr Oncol. 2020 Mar;11(2):335-337. doi: 10.1016/j.jgo.2019.05.018. Epub 2019 May 31. J Geriatr Oncol. 2020. PMID: 31160209 No abstract available.
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials.
Pasalic D, McGinnis GJ, Fuller CD, Grossberg AJ, Verma V, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Diefenhardt M, Das P, Subbiah V, Subbiah IM, Jagsi R, Garden AS, Fokas E, Rödel C, Thomas CR Jr, Minsky BD, Ludmir EB. Pasalic D, et al. Among authors: subbiah im, subbiah v. Eur J Cancer. 2020 Sep;136:176-185. doi: 10.1016/j.ejca.2020.06.015. Epub 2020 Jul 20. Eur J Cancer. 2020. PMID: 32702645 Free PMC article. Review.
Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials.
Lin TA, Fuller CD, Verma V, Mainwaring W, Espinoza AF, Miller AB, Jethanandani A, Pasalic D, Das P, Minsky BD, Thomas CR Jr, Fogelman DR, Subbiah V, Subbiah IM, Ludmir EB. Lin TA, et al. Among authors: subbiah im, subbiah v. Cancers (Basel). 2020 Sep 16;12(9):2636. doi: 10.3390/cancers12092636. Cancers (Basel). 2020. PMID: 32947844 Free PMC article.
Performance Status Restriction in Phase III Cancer Clinical Trials.
Abi Jaoude J, Kouzy R, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Pasalic D, Verma V, VanderWalde NA, Smith BD, Smith GL, Fuller CD, Das P, Minsky BD, Rödel C, Fokas E, Jagsi R, Thomas CR, Subbiah IM, Taniguchi CM, Ludmir EB. Abi Jaoude J, et al. Among authors: subbiah im. J Natl Compr Canc Netw. 2020 Oct 1;18(10):1322-1326. doi: 10.6004/jnccn.2020.7578. Print 2020 Oct. J Natl Compr Canc Netw. 2020. PMID: 33022640 Free PMC article.
78 results